Kodiak Sciences Earnings
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
99.87+5.61 (+5.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kodiak Sciences earnings summary
In its most recent report on Aug 13, 2026 (Q2 2026), KOD posted EPS of $-1.05. Across the last 16 reports, KOD shares moved an average of 9.5% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
KOD earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $-1.05 | — | -7.3% |
| May 7, 2026 | — | $-0.94 | — | -9.7% |
| Mar 31, 2026 | — | $-1.04 | — | +6.1% |
| Nov 13, 2025 | — | $-1.16 | — | +6.5% |
| Aug 13, 2025 | — | $-1.03 | — | -3.5% |
| May 14, 2025 | — | $-1.09 | — | -1.7% |
| Mar 27, 2025 | — | $-0.83 | — | -19.2% |
| Nov 14, 2024 | — | $-0.84 | — | +11.9% |
| Aug 14, 2024 | — | $-0.86 | — | +16.2% |
| May 15, 2024 | — | $-0.82 | — | -7.0% |
| Mar 28, 2024 | — | $-1.14 | — | -21.7% |
| Nov 14, 2023 | — | $-0.95 | — | +7.2% |
| Aug 14, 2023 | — | $-1.53 | — | -8.8% |
| May 15, 2023 | — | $-1.35 | — | +1.7% |
| Mar 28, 2023 | — | $-1.35 | — | -23.2% |
| Nov 9, 2022 | — | $-1.47 | — | +0.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.